Reimbursement Support

Reimbursement Support Services Overview
Co-Pay Assistance Program
Genentech Access Solutions: Coverage and Reimbursement
 

Helping to meet the diverse coverage and reimbursement needs of your patients

Click on the video below to learn about reimbursement information related to Rituxan.

Genentech Rheumatology Access Solutions helps your office resolve coverage- and reimbursement-related issues:

  • Benefit investigations
  • Prior authorization and recertification assistance
  • Helps with appeals
  • Answers to questions about billing
 

Please visit RheumatologyAccessSolutions.com or contact Genentech Rheumatology Access Solutions at (866) 681-3261 for complete program terms and eligibility requirements.

*
The RITUXAN EXPERIENCE Program is not a benefit plan. This program helps with your co-pay for the Rituxan drug only. it does not pay for other costs related to your visit or infusion. Providers must not seek reimbursement from any third-party payer for any amount provided by the RITUXAN EXPERIENCE MasterCard.
†
We cannot guarantee co-pay assistance once you have been referred by Genentech Access Solutions. The INOs to which we refer patients each have their own criteria with regard to eligibility, including financial eligibility. We do not influence or control the operations of these INOs, but Genentech Access Solutions can help you navigate the process of seeking co-pay assistance by referring you to an appropriate organization and by assisting with the application process.
 

To learn more about how Genentech Access Solutions can help your patients, call (866) 681-3261 or visit GenentechAccessSolutions.com

Genentech and Biogen Idec reserve the right to revise or terminate the program, in whole or in part, without notice, at any time.

The RITUXAN EXPERIENCE Program Card is issued by The Bancorp Bank pursuant to license by MasterCard International. MasterCard is a registered trademark of MasterCard International Incorporated. This card may not be used everywhere Debit MasterCard is accepted. No cash or ATM access. The Bancorp Bank; Member FDIC.

Patient Assistance
Referrals for Co-Pay Assistance

May we also suggest

INDICATION

Rituxan (rituximab) in combination with methotrexate is indicated for the treatment of adult patients with moderately- to severely- active rheumatoid arthritis who have had an inadequate response to one or more TNF antagonist therapies.

Rituxan is not recommended for treatment of patients with severe active infections.

IMPORTANT SAFETY INFORMATION

BOXED WARNINGS

Rituxan administration can result in serious, including fatal, adverse reactions. These include:

WARNINGS AND PRECAUTIONS

Rituxan administration can also result in additional serious, including fatal, adverse reactions including:

Patients should be closely observed for signs of infection if biologic agents and /or DMARDs other than methotrexate are used concomitantly.

Common adverse reactions include infusion reactions and infections.

For additional safety information, please see the full prescribing information, including BOXED WARNINGS and Medication Guide.

Attention Healthcare Provider: Provide Medication Guide to patient prior to Rituxan infusion.

Indication & Safety INFORMATION

Please acknowledge that you have read the below Important Safety Information by checking the box at the bottom of the screen.

Check By checking this box, I verify that I have read this Important Safety Information and that I am a U.S. Health Care Professional.